We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
3i Group Plc | LSE:III | London | Ordinary Share | GB00B1YW4409 | ORD 73 19/22P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 0.13% | 2,970.00 | 2,970.00 | 2,971.00 | 2,979.00 | 2,957.00 | 2,975.00 | 560,887 | 15:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 2.57B | 4.57B | 4.6982 | 6.33 | 28.95B |
3i Group PLC (III.LN) has hired Bank of America Merrill Lynch (BAC) to sell Belgian chemicals company Azelis, a person familiar with the situation told Dow Jones Newswires Friday.
3i invested EUR72 million in the company in December 2006 as part of a EUR315 million deal in which it acquired a 60% stake.
Azelis, which distributes chemicals for paints and polymers for plastics manufacture across 26 markets in Europe, has sales of around EUR1 billion and is valued at over EUR500 million.
Azelis is just one of several chemicals companies involved in current merger and acquisition activity. Just last week Bridgepoint bought German specialty chemicals company CABB from AXA Private Equity, while the auction of Germany's Evonik Industries AG's Carbon Black business reaches its final stages with three bidders remaining.
-By Marietta Cauchi, Dow Jones Newswires; +44 207 842 9241; marietta.cauchi@dowjones.com
1 Year 3i Chart |
1 Month 3i Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions